Solventum Corporation logo
Solventum Corporation (SOLV)
Compare

Solventum Corporation (SOLV) EV/EBITDA Ratio: 6.69x

popular:market cap|pe ratio|revenue|price history|total return

Is Solventum Corporation’s EV/EBITDA ratio high or low?

Solventum Corporation's EV/EBITDA ratio of 6.69x is 35% below its 2-year average of 10.29x, near the low end of its 2-year range (5.37x–16.34x).

As of Friday, June 12, 2026. 34.22% below its 12-month average of 10.17x.

EV/Sales|P/E Ratio|EBITDA|All Metrics

SOLV EV/EBITDA Ratio Chart

SOLV EV/EBITDA Ratio
6.69x-57.63% 1Y
Zoom

SOLV Average EV/EBITDA Ratio Chart

SOLV Current vs Average EV/EBITDA Ratio Chart

SOLV EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

6.69x

EV/EBITDA RATIO AVG TTM

10.17x

EV/EBITDA RATIO AVG 3Y

10.29x

EV/EBITDA RATIO AVG 5Y

10.29x

EV/EBITDA RATIO AVG 10Y

10.29x

EV/EBITDA RATIO AVG 15Y

10.29x

EV/EBITDA RATIO AVG 20Y

10.29x

CURRENT VS TTM AVG

-34.22%

CURRENT VS 3Y AVG

-35.00%

CURRENT VS 5Y AVG

-35.00%

CURRENT VS 10Y AVG

-35.00%

CURRENT VS 15Y AVG

-35.00%

CURRENT VS 20Y AVG

-35.00%

SOLV Competitors' EV/EBITDA Ratio

NAMEMARKET CAPEV/EBITDA RATIOTTM3Y5Y
Solventum Corporation (SOLV)$13.72B6.69x10.17x10.29x10.29x
Align Technology, Inc. (ALGN)$12.64B14.70x13.79x20.53x26.15x
Baxter International Inc. (BAX)$10.58B24.69x20.33x19.11x19.11x
Hologic, Inc. (HOLX)$16.97B17.28x15.01x15.35x12.41x
Charles River Laboratories International, Inc. (CRL)$9.06B41.54x24.37x17.33x18.47x
Tempus AI, Inc. (TEM)$8.65BN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. (BIO)$7.91B20.42x12.17x62.61x32.85x
Moderna, Inc. (MRNA)$19.70BN/A12.39x25.27x25.27x
Hims & Hers Health, Inc. (HIMS)$6.44B249.61x76.65x128.01x128.01x
BioNTech SE (BNTX)$22.39BN/A51.40x19.63x20.05x

EV/EBITDA vs. its own history

At 6.7, EV/EBITDA is cheaper than usual, sitting higher than 19% of its 2-year history.

2-year low

5.4

median

9.6

2-year high

16.3

cheaperricher

Solventum Corporation EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Solventum Corporation EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Solventum Corporation (SOLV)?
The EV/EBITDA ratio for SOLV stock is 6.69x.
Is Solventum Corporation's EV/EBITDA ratio high or low?
Solventum Corporation's EV/EBITDA ratio of 6.69x is 35% below its 2-year average of 10.29x, near the low end of its 2-year range (5.37x–16.34x).
What is the TTM average EV/EBITDA ratio for Solventum Corporation (SOLV)?
The TTM average EV/EBITDA ratio for SOLV stock is 10.17x.
What is the 3Y average EV/EBITDA ratio for Solventum Corporation (SOLV)?
The 3Y average EV/EBITDA ratio for SOLV stock is 10.29x.
What is the 5Y average EV/EBITDA ratio for Solventum Corporation (SOLV)?
The 5Y average EV/EBITDA ratio for SOLV stock is 10.29x.
What is the 10Y average EV/EBITDA ratio for Solventum Corporation (SOLV)?
The 10Y average EV/EBITDA ratio for SOLV stock is 10.29x.
What is the 15Y average EV/EBITDA ratio for Solventum Corporation (SOLV)?
The 15Y average EV/EBITDA ratio for SOLV stock is 10.29x.
What is the 20Y average EV/EBITDA ratio for Solventum Corporation (SOLV)?
The 20Y average EV/EBITDA ratio for SOLV stock is 10.29x.

Solventum Corporation EV/EBITDA Ratio History

DATEEV/EBITDA RATIO
2026-06-116.69x
2026-06-106.80x
2026-06-096.90x
2026-06-086.66x
2026-06-056.80x
2026-06-046.89x
2026-06-036.63x
2026-06-026.51x
2026-06-016.47x
2026-05-296.42x
2026-05-286.48x
2026-05-276.48x
2026-05-266.50x
2026-05-226.54x
2026-05-216.53x
2026-05-206.49x
2026-05-196.40x
2026-05-186.49x
2026-05-156.37x
2026-05-146.38x
2026-05-136.38x
2026-05-126.43x
2026-05-116.36x
2026-05-086.32x
2026-05-076.21x
2026-05-066.17x
2026-05-056.04x
2026-05-045.68x
2026-05-015.63x
2026-04-305.68x
2026-04-295.62x
2026-04-285.69x
2026-04-275.83x
2026-04-245.75x
2026-04-235.78x
2026-04-225.79x
2026-04-215.78x
2026-04-205.84x
2026-04-175.87x
2026-04-165.77x
2026-04-155.79x
2026-04-145.78x
2026-04-135.68x
2026-04-105.58x
2026-04-095.60x
2026-04-085.55x
2026-04-075.37x
2026-04-065.42x
2026-04-025.44x
2026-04-015.49x
2026-03-315.55x
2026-03-305.43x
2026-03-275.39x
2026-03-265.51x
2026-03-255.51x
2026-03-245.47x
2026-03-235.57x
2026-03-205.58x
2026-03-195.66x
2026-03-185.66x
2026-03-175.76x
2026-03-165.66x
2026-03-135.64x
2026-03-125.60x
2026-03-115.69x
2026-03-105.69x
2026-03-095.75x
2026-03-065.81x
2026-03-055.89x
2026-03-045.87x
2026-03-035.89x
2026-03-026.03x
2026-02-276.10x
2026-02-266.55x
2026-02-256.43x
2026-02-246.31x
2026-02-236.26x
2026-02-206.28x
2026-02-196.33x
2026-02-186.42x
2026-02-176.34x
2026-02-136.46x
2026-02-126.49x
2026-02-116.86x
2026-02-106.79x
2026-02-096.63x
2026-02-066.63x
2026-02-056.56x
2026-02-046.52x
2026-02-036.47x
2026-02-026.55x
2026-01-306.55x
2026-01-296.52x
2026-01-286.53x
2026-01-276.60x
2026-01-266.69x
2026-01-236.69x
2026-01-226.78x
2026-01-216.78x
2026-01-206.69x
2026-01-166.72x
2026-01-156.79x
2026-01-146.76x
2026-01-136.76x
2026-01-127.14x
2026-01-097.17x
2026-01-087.15x
2026-01-077.05x
2026-01-066.97x
2026-01-056.81x
2026-01-026.69x
2025-12-316.71x
2025-12-306.77x
2025-12-296.77x
2025-12-266.79x
2025-12-246.77x
2025-12-236.80x
2025-12-226.81x
2025-12-196.87x
2025-12-186.81x
2025-12-176.76x
2025-12-166.80x
2025-12-156.89x
2025-12-126.96x
2025-12-116.95x
2025-12-106.89x
2025-12-096.77x
2025-12-086.94x
2025-12-057.13x
2025-12-047.12x
2025-12-037.11x
2025-12-027.14x
2025-12-017.14x
2025-11-287.12x
2025-11-267.12x
2025-11-257.15x
2025-11-246.99x
2025-11-216.96x
2025-11-206.73x
2025-11-196.58x
2025-11-186.55x
2025-11-176.50x
2025-11-146.47x
2025-11-136.44x
2025-11-126.34x
2025-11-116.35x
2025-11-106.20x
2025-11-076.19x
2025-11-065.83x
2025-11-0515.03x
2025-11-0415.16x
2025-11-0315.09x
2025-10-3115.22x
2025-10-3015.25x
2025-10-2915.32x
2025-10-2815.48x
2025-10-2715.62x
2025-10-2415.55x
2025-10-2315.66x
2025-10-2215.73x
2025-10-2115.75x
2025-10-2015.74x
2025-10-1715.65x
2025-10-1615.55x
2025-10-1515.56x
2025-10-1415.55x
2025-10-1315.47x
2025-10-1015.42x
2025-10-0915.60x
2025-10-0815.68x
2025-10-0715.65x
2025-10-0615.87x
2025-10-0315.90x
2025-10-0215.98x
2025-10-0115.77x
2025-09-3015.76x
2025-09-2915.65x
2025-09-2615.54x
2025-09-2515.41x
2025-09-2415.60x
2025-09-2315.82x
2025-09-2215.87x
2025-09-1915.86x
2025-09-1815.95x
2025-09-1715.91x
2025-09-1615.92x
2025-09-1515.79x
2025-09-1215.82x
2025-09-1115.87x
2025-09-1015.52x
2025-09-0915.75x
2025-09-0815.98x
2025-09-0515.72x
2025-09-0415.68x
2025-09-0315.54x
2025-09-0215.60x
2025-08-2915.77x
2025-08-2815.72x
2025-08-2715.75x
2025-08-2615.75x
2025-08-2515.73x
2025-08-2215.84x
2025-08-2115.62x
2025-08-2015.74x
2025-08-1915.66x
2025-08-1815.45x
2025-08-1515.55x
2025-08-1415.79x
2025-08-1315.95x
2025-08-1215.64x
2025-08-1115.61x
2025-08-0815.82x
2025-08-0715.62x
2025-08-0615.54x
2025-08-0515.52x
2025-08-0415.63x
2025-08-0115.43x
2025-07-3115.38x
2025-07-3015.60x
2025-07-2915.67x
2025-07-2815.70x
2025-07-2515.84x
2025-07-2415.73x
2025-07-2315.79x
2025-07-2215.59x
2025-07-2115.51x
2025-07-1815.64x
2025-07-1715.72x
2025-07-1615.60x
2025-07-1515.69x
2025-07-1415.74x
2025-07-1115.71x
2025-07-1015.99x
2025-07-0915.76x
2025-07-0815.88x
2025-07-0716.04x
2025-07-0316.34x
2025-07-0216.31x
2025-07-0116.26x
2025-06-3015.98x
2025-06-2715.93x
2025-06-2615.82x
2025-06-2515.86x
2025-06-2415.87x
2025-06-2315.63x
2025-06-2015.68x
2025-06-1815.55x
2025-06-1715.57x
2025-06-1615.80x
2025-06-1315.71x
2025-06-1215.77x
2025-06-1115.79x
2025-06-1015.95x
2025-06-0915.86x
2025-06-0615.85x
2025-06-0515.92x
2025-06-0415.89x
2025-06-0315.77x
2025-06-0215.62x
2025-05-3015.61x

Showing the most recent 260 of 555 data points. The chart above shows the full history.

Related Metrics

EV/SalesP/E RatioEBITDAAll Metrics

About Solventum Corporation

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Maplewood, MN
22,000 employees
www.solventum.com
Healthcare / Medical - Care Facilities
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Bryan C. Hanson
View full financials